DCF — NYC HEALTH + HOSPITAL / SOUTH BROOKL
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-453.0M
PV of Cash Flows
$-1.0B
PV of Terminal Value
$-1.6B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $606.2M | $-97.0M | -16.0% | $-122.6M | $-111.5M |
| Year 2 | $624.4M | $-93.6M | -15.0% | $-120.1M | $-99.2M |
| Year 3 | $643.1M | $-90.0M | -14.0% | $-117.2M | $-88.1M |
| Year 4 | $662.4M | $-89.4M | -13.0% | $-117.4M | $-80.2M |
| Year 5 | $682.2M | $-90.4M | -13.0% | $-119.3M | $-74.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$588.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16496225725215496
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5